PNRI Features Nuclear Applications at the 2018 National Science and Technology Week
Featuring the latest innovations in nuclear science and technology through its applications in food, agriculture and radiation safety, the Department of Science and Technology – Philippine Nuclear Research Institute (DOST-PNRI) participates in the celebration of the National Science and Technology Week (NSTW) on July 17 to 21 at the World Trade Center in Pasay City.
With the theme, "Science for the People: Innovation for Collective Prosperity", the 2018 NSTW will feature interactive exhibits divided in four clusters depicting Science, Technology and Innovation (STI) at Home, School, Workplace and Marketplace.
For this year’s celebration, PNRI exhibits several projects and technologies in STI at Home, such as monitoring of radon, a radioactive gas, improved ornamentals through mutation breeding, nuclear analytical techniques for analysis of synthetic acetic acid adulteration in vinegar, and irradiation of burger patties for food safety.
For STI in the Workplace – Farmville, PNRI features its award-winning Carrageenan Plant Growth Promoter as plant food supplement for mungbean that will improve the yield and quality of our food crops. Finally, PNRI also participates in STI in School with two learning stations on radiation detection and cloud chamber experiments, which will be more engaging to students in demystifying nuclear reactions.
Held annually every third week of July, the NSTW aims to recognize the contribution of science and technology in the development of the country and garner support from the public and private institutions for its sustainable development, according to the DOST.
Find out more about PNRI exhibits during the 2018 NSTW at our PNRI Facebook Page:
Dr. Chitho Feliciano (middle) receives the First Prize Award for the 2018 National Academy of Science and Technology (NAST) Talent Search for Young Scientists, awarded on July 12, 2018 at the Manila Hotel during the NAST 40th Annual Scientific Meeting. He is joined by Department of Science and Technology (DOST) Secretary Fortunato De La Peña (right) and NAST President, Acd. Rhodora Azanza (left).
PNRI Researcher Wins 2018 NAST Talent Search for Young Scientists
For his contribution to the field of radiation biology and nanomedicine research, Dr. Chitho Feliciano of the Department of Science and Technology – Philippine Nuclear Research Institute (DOST – PNRI) recently won the First Prize for the 2018 National Academy of Science and Technology (NAST) Talent Search for Young Scientists.
Dr. Feliciano received the award along with several other outstanding scientists and researchers who won in various categories during the closing of the NAST 40th Annual Scientific Meeting held at the Manila Hotel on July 12, 2018. The award includes a plaque of recognition, cash prize, and research grant from the DOST.
Dr. Feliciano joined the PNRI in 2004 under the Atomic Research Division of the Institute. In 2013, He was awarded with a Japanese Government Ph.D. Scholarship (Monbukagakusho) and finished his doctorate degree in Materials Science with special focus in Radiation Research at the University of Tsukuba, Japan in 2017.
His research projects in radiation biology and nanomedicines aim to improve protection measures against accidental exposure of radiation workers, patients and the general public to ionizing radiation. Many of these projects also won numerous awards in local and international scientific meetings and conferences since 2008. A prolific writer with eleven scientific articles in internationally-indexed peer-reviewed journals, he also served as the editor-in-chief of the Philippine Nuclear Journal, and serves as a reviewer of several international Scopus indexed journals.
Dr. Feliciano currently serves as the Section Head of the PNRI Health Physics Research Section – one of the youngest in the history of the Institute. The section conducts research projects involving radiation biology research and environmental radioactivity monitoring. He is also a regular member of the National Research Council of the Philippines (NRCP), One Expert Philippines and the International Radiation Research Society (RRS).
President Duterte Visits PNRI at Mindanao NSTW 2018 - Davao
During the 2018 Mindanao National Science and Technology Week on July 6, 2018, President Rodrigo Duterte, Representative Karlo Nograles of 1st District, Davao City and Secretary Fortunato de la Peña visited the PNRI booth on the latest applications of nuclear science and technology, as explained by PNRI Director Dr. Carlo Arcilla.
Dr. Arcilla was joined by Atomic Research Division Chief and Career Scientist Dr. Lucille Abad, and Technology Diffusion Division Chief Ms. Ana Elena Conjares.
Among the nuclear science and technology applications featured are the Carrageenan PGP as Plant Food Supplement, PVP Hydrogel Wound Dressings for wounds and bedsores, food irradiation for longer shelf-life and hemostats for wounds and skin openings.
The PNRI Technetium-99m (Tc-99m) Generator Facility (above) where the Institute produces the Tc-99m generator (below)
PNRI Revives Technetium-99m Production
Bringing the Philippines back on track in improving its nuclear medicine applications, the Department of Science and Technology – Philippine Nuclear Research Institute (DOST-PNRI) has restarted its production of Technetium-99m (Tc-99m) with resources from other countries.
With PNRI’s Tc-99m Generator Facility, the average cost for importing the workhorse radiopharmaceutical can be lowered by around 20 percent.
A medical radioisotope generated from Molybdenum-99m (Mo-99), Tc-99m allows doctors to scan and provide an image of various organs in the body, used in more than 80 percent of the world’s nuclear diagnostic imaging procedures.
With a short half-life of 6 hours, Tc-99m emits gamma rays which makes it very useful as a tracer in helping to diagnose various physical ailments and abnormalities at the early stages while minimizing the exposure of patients to radiation.
After negotiations with the Rosatom State Nuclear Energy Corporation (ROSATOM) in Russia, PNRI Director Dr. Carlo Arcilla was able to secure a fresh shipment of Mo-99 from Moscow for the Institute’s operation of the generator facility, with the initial Tc-99m eluates to be used for unit dose training.
With the expected arrival of another batch of Mo-99m from Indonesia, PNRI plans to begin commercializing the Tc-99m radiopharmaceutical in the near future. The generator facility hopes to serve the needs of more than 40 nuclear medicine centers across the country.
PNRI has obtained a license to operate the Tc-99m facility from the Food and Drug Administration (FDA) in 2014.